Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Pathological Examination Market to Reach $438.16 Bn, Globally, by 2025 at 12.3% CAGR: AMR


PORTLAND, Oregon, April 24, 2019 /PRNewswire/ -- Allied Market Research recently published a report, titled, Pathological Examination Market by Type (Traditional Pathology and Digital Pathology) and Application (Digestive Organs and Other Applications): Global Opportunity Analysis and Industry Forecast, 2017 - 2025. The research offers a detailed analysis on changing market dynamics, key investment pockets, major segments, and market competition. According to the report, the global pathological examination market generated $171.08 billion in 2017, and is expected to reach $438.16 billion by 2025, growing at a CAGR of 12.3% from 2019 to 2025.

AMR Logo

Factors such as increase in prevalence of chronic diseases and high focus on early diagnosis of diseases drive the market growth. However, shortage of pathologists and skilled technicians restrains the growth of the market. Conversely, use of digital pathology in disease diagnosis create new opportunities for growth of the market.

Other applications segment to be lucrative through 2025

Among applications, the other applications segment accounted for more than three-fourths of the market share in 2017 and would retain its dominance through 2025. The same would grow at the fastest CAGR of 13% during the forecast period. This is due to the high adoption of pathological examinations for diagnosis and treatment of various disease classes such as cancer, gynecology, and diabetes as well as increasing prevalence of chronic diseases worldwide. The report also analyzes applications such as digestive organs.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5242 

Traditional segment to lead in terms of revenue through 2025

Among types, the traditional segment was the largest in 2017, capturing 91% of the market share and would maintain its dominance through 2025. However, the digital segment would grow at the fastest CAGR of 15.4% from 2019 to 2025.

Asia to be the fastest growing region through 2025

The market in the U.S. was the largest in 2017, grabbing more than half of the market share and is likely to dominate the market through 2025. This is due to early diagnosis, high purchasing power, wide availability of advanced technologies, and better reimbursement policies in the region. However, the market in Asia would achieve the fastest CAGR of 15.2% during the forecast period. This is due to the rise in incidence of chronic diseases, developing healthcare infrastructure, growing healthcare awareness, and growing awareness for early screening or diagnosis of the diseases. The report also analyzes regions such as Europe and rest of the world.

Key players of the industry

Leading market players analyzed in the research include Quest Diagnostics, Inc., Sonic Healthcare Limited, Spectra Laboratories, Diagnostic Pathology Services, Inc., Q2 Solutions, Histo-Scientific Research Laboratories, among others. These market players have adopted various strategies including collaborations, joint ventures, partnerships, expansions, and others to gain a strong position in the industry.

Do Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/5242 

Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at: https://www.alliedmarketresearch.com/knowledgetree

Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.

Similar Reports:

Pathology Market - Global Opportunity Analysis and Industry Forecast, 2018-2025

Digital Pathology Market - Global Opportunity Analysis and Industry Forecast, 2017-2023

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com

SOURCE Allied Market Research


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: